The three topics presented at the APS conference are:
- The results of a survey, showing that more than four of every five patients (87%) who used a compounded prescription, non-opioid topical pain cream said their pain lessened after using the cream, reducing their pain levels by more than half over a 24-hour period. In addition, 42% indicated their use of oral pain medications had decreased. The patients surveyed suffered from chronic pain, and were covered by TRICARE, the government’s healthcare plan for members of the military and their families.
- The results of another survey, reporting that almost 3,600 chronic pain sufferers reported a significant reduction in their pain levels after using the compounded prescription cream. The participants said their pain levels decreased, on average, by 20 percent after four weeks’ continuous use of the cream. More than 70 percent said their pain had lessened, with an average 24-hour reduction of 58 percent; 38 percent indicated their use of oral pain medication had decreased, echoing the study mentioned above.
- A graphic illustrating POA’s newly developed integrative model to improve pain management. The model shows how data from patients using personalized compounded transdermal pain creams is collected, analyzed by POA scientists, validated by an outcomes research company and presented on a doctors’ portal site where physicians can monitor the progress of their patients’ treatments.
Full article available here: http://globenewswire.com/news-release/2014/04/21/628213/10077391/en/Studies-Reporting-Significant-Reduction-in-Chronic-Pain-Via-Non-Opioid-Prescription-Creams-to-be-Presented-at-American-Pain-Society-Conference.html#sthash.unNTk3Xg.dpuf